Wird geladen...
Acute respiratory distress syndrome; A rare complication caused by usage of ruxolitinib
Ruxolitinib-associated acute respiratory distress has rarely been reported, mostly due to discontinuation of treatment. Herein we report a 58-year-old male patient with primary myelofibrosis who presented with malaise and dyspnea 15 days after initiation of the treatment. The patient was diagnosed a...
Gespeichert in:
| Veröffentlicht in: | Respir Med Case Rep |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5608559/ https://ncbi.nlm.nih.gov/pubmed/28970999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2017.09.003 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|